JHS Svendgaard Laboratories has scheduled its 22nd Annual General Meeting for September 26, 2026. The event will be conducted through video conferencing or other audio-visual means in compliance with Ministry of Corporate Affairs and SEBI regulations.

The company confirmed that the Notice of the AGM and the Annual Report for the financial year ended March 31, 2026, will be sent electronically to members with registered email addresses as of the cut-off date of August 28, 2026. Physical copies have been dispensed with per applicable circulars.

Meeting Details

The registered office of the company will be deemed as the venue for the AGM. Shareholders can access the Notice and Annual Report on the company’s website and the stock exchange portals of BSE and NSE. The documents are also available on the National Securities Depository Limited (NSDL) e-voting platform.

Voting and Participation

Remote e-voting and e-voting at the AGM will be facilitated by NSDL. Members holding shares in physical form or those without registered email IDs can obtain voting credentials by writing to the Registrar and Share Transfer Agent, Beetal Financial & Computer Services Private Limited.

For queries regarding the AGM, members may contact Ms. Pallavi Mhatre at NSDL. The company has also noted the availability of a special window for the transfer and dematerialisation of physical securities from February 5, 2026, to February 4, 2027.

JHS Svendgaard Laboratories returned to profitability in Q1FY26, reporting a standalone net profit of ₹109.15 lakh compared to a net loss of ₹356.56 lakh in Q4FY25. The oral care manufacturer saw its revenue from operations rise 29.5% year-on-year to ₹3,038.05 lakh, driven by improved operational efficiency that narrowed the gap between income and expenses. Consolidated results mirrored this trend, with net profit attributable to owners of the company reaching ₹109.04 lakh. This turnaround signals a stabilization in core operations after periods of volatility, offering a positive outlook for shareholders despite thin pre-tax margins.

The Board of Directors approved the unaudited standalone and consolidated financial results on August 11, 2026, pursuant to Regulations 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Statutory auditors V.K. Khosla & Co. issued limited review reports on the results, confirming compliance with Ind AS 34 and other generally accepted accounting principles in India. The company operates with a single reportable segment for oral care products under Ind AS 108.

Financial Performance

Revenue from operations increased from ₹2,345.41 lakh in Q1FY25 to ₹3,038.05 lakh in Q1FY26. However, cost of materials consumed also rose significantly to ₹1,873.26 lakh from ₹1,421.83 lakh in the same period last year. Employee benefits expense grew to ₹287.44 lakh from ₹266.53 lakh, while finance costs doubled to ₹28.40 lakh from ₹15.67 lakh. Despite higher costs, total expenses remained tightly controlled at ₹3,040.82 lakh against total income of ₹3,047.11 lakh, resulting in a pre-tax profit of ₹6.29 lakh.

The improvement in bottom-line performance was largely aided by deferred tax benefits. Deferred tax income stood at ₹128.29 lakh, partially offset by tax provisions for earlier years amounting to ₹25.42 lakh. This resulted in a net tax credit that transformed the modest pre-tax profit into a significant net profit figure. Earnings per share improved to ₹0.13 from a loss of ₹0.42 in the previous quarter.

Capital Allocation and Utilization

The company provided updates on the utilization of funds raised through a preferential issue of equity shares and fully convertible warrants. Of the ₹2,625 lakh received, ₹71.29 lakh was utilized for a project in Jammu and Kashmir, while ₹749.50 lakh was allocated to general corporate purposes. Significant portions were directed towards strategic investments, including ₹112.50 lakh for preferential warrants in JHS Svendgaard Retail Ventures Limited and an ₹850 lakh loan to the same entity. Capital expenditure accounted for ₹693.18 lakh, with a balance of ₹148.53 lakh parked in fixed deposits pending further utilization.

What the Numbers Show

The primary driver of the profitability turnaround was not just top-line growth but a substantial reduction in operating losses relative to the previous quarter. While Q4FY25 saw a pre-tax loss of ₹297.91 lakh, Q1FY26 achieved a pre-tax profit of ₹6.29 lakh despite higher input costs. This suggests improved margin management or operational leverage in the current quarter. However, investors should note that other income declined sharply to ₹9.06 lakh from ₹72.66 lakh in Q4FY25, indicating that the core operational improvement is the key factor behind the positive result rather than incidental gains.